论文部分内容阅读
1.我国生化制药已经形成体系我国的生化制约工业,是在综合利用畜禽脏器资源的基础上发展起来的,迄今已有30多年的历史。到1978年,全国有188家生化制药单位,生产112个品种,但绝大多数是粗制品或初级产品,工业总产值1.2亿元,其中滋补营养药产值占80%以上。改革开放以来,我国生化制药工业得到了长足的发展。过去依靠进口的胰岛素、细胞色素C等已能自给,主要出口产品有肝素钠、尿激酶、HCG、HMG、胰酶、胰激肽释放酶、胃酶等,销往国际市
1. China’s biochemical pharmaceutical industry has formed a system in China’s biochemical control industry, is based on the comprehensive utilization of livestock and poultry organ resources developed on the basis of so far has more than 30 years of history. By 1978, there were 188 biochemical pharmaceutical units in the country, producing 112 varieties, but the vast majority were crude or primary products. The total industrial output value was 120 million yuan, of which nourishing nutritional products accounted for more than 80%. Since the reform and opening up, China’s biochemical pharmaceutical industry has made considerable progress. In the past, relying on imports of insulin, cytochrome C, etc. have become self-sufficient. The main export products are heparin sodium, urokinase, HCG, HMG, trypsin, kallikrein, and stomach enzymes, etc., sold to international markets.